Seer, (id:8189 SEER)

2.43 USD

Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/24/2024 4:19:37 PM)

Exchange closed, opens in 17 hours 10 minutes

• 1 day
• 1 week
• 1 month
• 6 months
• 1 year
• All

About Seer,

Market Capitalization 136.21M

Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company intends to sell its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It operates in China, Australia, Eastern Europe, Israel, and Japan. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.